1)Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126:1634-1648, 2004
2)Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 148:639-651, 2015
3)Sugimoto S, Naganuma M, Iwao Y, et al. Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc 85:639-646, 2017
4)Kinoshita S, Uraoka T, Nishizawa T, et al. The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis. Gastrointest Endosc 87:1079-1084, 2018
5)Kawasaki K, Nakamura S, Esaki M, et al. Clinical usefulness of magnifying colonoscopy for the diagnosis of ulcerative colitis-associated neoplasia. Dig Endosc 31(Suppl 1):36-42, 2019
6)Hata K, Watanabe T, Motoi T, et al. Pitfalls of pit pattern diagnosis in ulcerative colitis-associated dysplasia. Gastroenterology 126:374-376, 2004
7)Matsumoto T, Kudo T, Jo Y, et al. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis:a pilot study. Gastrointest Endosc 66:957-965, 2007
8)Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343:71-74, 1994
9)Leidenius M, Kellokumpu I, Husa A, et al. Dysplasia and carcinoma in longstanding ulcerative colitis:an endoscopic and histological surveillance programme. Gut 32:1521-1525, 1991